blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3116498

EP3116498 - FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.10.2019
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  09.11.2018
FormerGrant of patent is intended
Status updated on  12.07.2018
FormerRequest for examination was made
Status updated on  16.12.2016
FormerThe international publication has been made
Status updated on  16.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Bodor Laboratories, Inc.
4400 Biscayne Boulevard
Suite 980
Miami, FL 33137 / US
[2017/03]
Inventor(s)01 / BODOR, Nicholas S.
10225 Collins Avenue
Units 1002/1004
Bal Harbour, Florida 33154 / US
02 / KOLENG, John J.
11113 Alison Park Trail
Austin, Texas 78750 / US
03 / ANGULO, David
2600 SW 3rd Avenue
Suite 350
Miami, Florida 33129 / US
 [2017/03]
Representative(s)V.O.
P.O. Box 87930
Carnegieplein 5
2508 DH Den Haag / NL
[2017/03]
Application number, filing date15762178.012.03.2015
[2017/03]
WO2015US20253
Priority number, dateUS201461952505P13.03.2014         Original published format: US 201461952505 P
US20141428548822.05.2014         Original published format: US201414285488
[2017/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015138776
Date:17.09.2015
Language:EN
[2015/37]
Type: A1 Application with search report 
No.:EP3116498
Date:18.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 17.09.2015 takes the place of the publication of the European patent application.
[2017/03]
Type: B1 Patent specification 
No.:EP3116498
Date:12.12.2018
Language:EN
[2018/50]
Search report(s)International search report - published on:US17.09.2015
(Supplementary) European search report - dispatched on:EP06.10.2017
ClassificationIPC:A61K47/10, A61K9/08, A61K31/40, A61K31/56
[2017/45]
CPC:
C07D207/12 (EP,US); A61K31/40 (EP,IL,KR,US); A61K31/56 (IL);
A61K33/06 (EP,US); A61K47/10 (EP,KR,US); A61K47/12 (EP,KR,US);
A61K47/24 (EP,KR,US); A61K47/34 (EP,US); A61K47/38 (EP,KR,US);
A61K8/4913 (EP,US); A61K9/0014 (EP,KR,US); A61K9/06 (EP,KR,US);
A61K9/08 (EP,KR,US); A61P17/00 (EP,KR); A61P43/00 (EP,KR);
A61Q15/00 (EP,US) (-)
C-Set:
A61K31/40, A61K2300/00 (EP,US);
A61K33/06, A61K2300/00 (US,EP)
Former IPC [2017/03]A61K31/40, A61K31/56
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/03]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:FORMULIERUNG FÜR WEICHE ANTICHOLINERGISCHE ANALOGA[2017/03]
English:FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS[2017/03]
French:PRÉPARATION POUR ANALOGUES D'ANTICHOLINERGIQUES À POTENTIEL MODÉRÉ[2017/03]
Entry into regional phase11.10.2016National basic fee paid 
11.10.2016Search fee paid 
11.10.2016Designation fee(s) paid 
11.10.2016Examination fee paid 
Examination procedure11.10.2016Examination requested  [2017/03]
11.10.2016Date on which the examining division has become responsible
19.04.2018Amendment by applicant (claims and/or description)
13.07.2018Communication of intention to grant the patent
22.10.2018Fee for grant paid
22.10.2018Fee for publishing/printing paid
22.10.2018Receipt of the translation of the claim(s)
Opposition(s)13.09.2019No opposition filed within time limit [2019/47]
Fees paidRenewal fee
27.03.2017Renewal fee patent year 03
13.03.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL12.12.2018
CY12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
MC12.12.2018
MK12.12.2018
RO12.12.2018
RS12.12.2018
SI12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
MT12.03.2019
IS12.04.2019
[2022/31]
Former [2021/26]AL12.12.2018
CY12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
MC12.12.2018
RO12.12.2018
RS12.12.2018
SI12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
MT12.03.2019
IS12.04.2019
Former [2020/29]AL12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
MC12.12.2018
RO12.12.2018
RS12.12.2018
SI12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
MT12.03.2019
IS12.04.2019
Former [2019/50]AL12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
MC12.12.2018
RO12.12.2018
RS12.12.2018
SI12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
IS12.04.2019
Former [2019/46]AL12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
MC12.12.2018
RO12.12.2018
RS12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
IS12.04.2019
Former [2019/39]AL12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
RO12.12.2018
RS12.12.2018
SK12.12.2018
SM12.12.2018
BG12.03.2019
IS12.04.2019
Former [2019/37]AL12.12.2018
EE12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
RO12.12.2018
RS12.12.2018
SM12.12.2018
BG12.03.2019
Former [2019/26]AL12.12.2018
HR12.12.2018
LT12.12.2018
LV12.12.2018
RS12.12.2018
BG12.03.2019
Former [2019/25]HR12.12.2018
LT12.12.2018
LV12.12.2018
RS12.12.2018
BG12.03.2019
Former [2019/23]HR12.12.2018
LT12.12.2018
LV12.12.2018
BG12.03.2019
Former [2019/22]LT12.12.2018
BG12.03.2019
Former [2019/20]LT12.12.2018
Documents cited:Search[ID] US2009263341  (BODOR NICHOLAS S et al.) [ID] 1-17 * paragraphs 52, 75, 102, 111;; examples 30-35; claim 11; compound (m) *
 [AP] WO2014144075  (BODOR LAB INC et al.) [AP] 1-17 * examples 1-2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.